How Can PGx Testing Help Your Long-Term Care Facility?
Make It Personal.

IDgenetix® is an Advanced Pharmacogenomic (PGx) Test that Improves the Chances of Getting a Response or Remission.

Can IDgenetix® Help Improve Your Quality Rating?

For patients staying more than 100 days, the 9 quality measures for long-term stays include:

LTC Facility Experience

Facility Overview

200 residents assisted living facility, providing round the clock care to seniors with varying degrees of independence and physical/emotional requirements. Received a multitude of F-740 tags in regard to behavioral health care concerns. The majority of the residents were being treated with multiple antipsychotic medications, which led to a lengthy GDR list and frustration among caregivers. The facility’s Medicare rating was 3/5 stars due, in part, to behavioral health infractions.

Clinician Action

The facility’s Psychiatric Physician Assistant ordered pharmacogenomics testing for many of the residents on their GDR list. Utilizing the guidance of the IDgenetix® report, the clinician was able to streamline the medication management of these patients by selecting optimal psychiatric treatment regimens that work with the patients’ genetics.

Outcome

With these changes to the facility’s psychiatric medication management protocol, the facility was able to decrease their F-tag violations immediately and their GDR list was reduced by half.

01.

“Use as Directed” Medications: Among the genes analyzed, no genetic variants or metabolic interactions were identified that would suggest a need for increased caution or dose adjustments.

02.

“Use with Caution and/or Increased Monitoring Medications:” One or more genetic variants or metabolic interactions have been identified that would indicate a need for increased caution, dose adjustment or selection of alternate medication.

03.

Medications the patient is 3 currently taking are highlighted.

04.

The list of patient medications provided at the time of testing is used to display potential metabolic interactions with medications evaluated in the test panel.

05.

Genes, Genotype/Diplotype: Genes and genetic variants analyzed and the patient’s genetic variant result.

06.

Predicted drug metabolism phenotype. *See back of test for definition of different metabolizer phenotypes.

07.

Clinically significant: “Yes” indicates genetic variant impacts one or more messages in Use with Caution.

Exceptional Access is Available for your LTC Residents on Medicare

Medicare (Part B) Covered Tests

You will have a $0 out of pocket cost.

Medicare Advantage Covered Tests

You might have to cover a portion of the cost. (typically $330 or less)

Commercial or Other Insurance

Out-of-Network plans vary, but you may be expected to cover a portion of the cost (typically $330 or less). In-Network claims are subject to applicable co-pay, co insurance, and deductible amounts. AltheaDx is in-network with the Multiplan Network; your insurance provider/insurance ID card will indicate the specific network (i.e., MultiPlan, PHCS, Beech Street, AMN/HMN/RAN, IHP or ValuePoint).

Participating Medicaid States

Normally, you will have a $0 out of pocket cost.

Uninsured

Please contact us to find out how we can help.

Our team bills your insurance for the cost of the IDgenetix® test. If you have any questions, please contact an IDgenetix® Billing Specialist at 1-855-MY-PGX-ID or billing@idgenetix.com and we will be happy to assist you further. For those who qualify, we offer a financial assistance program to help with these out-of-pocket costs.

Get Started

Please register below or contact our customer service center at 1-855-MY-PGX-ID (1-855-697-4943) or support@idgenetix.com, or speak to your local IDgenetix® account manager to set up an online account and obtain IDgenetix® sample collection kits.